Dhanvantri Jeevan Rekha adopts FY26 financials, re-appoints directors

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Adopted audited standalone financial statements for FY26
  • Re-appointed Tulsi Prasad Sharma and Rowena Sharma as directors
  • AGM held on September 29, 2026, in Meerut
  • No queries raised by registered speakers during the meeting
powered bylight_fuzz_icon
52230801

*this image is generated using AI for illustrative purposes only.

Dhanvantri Jeevan Rekha Limited shareholders adopted the audited standalone financial statements for the financial year ended March 31, 2026, during the company's 33rd Annual General Meeting (AGM).

The meeting took place on September 29, 2026, at the company's registered office in Meerut, Uttar Pradesh. The proceedings were conducted pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key resolutions passed

During the ordinary business segment of the meeting, two directors who retired by rotation were re-appointed for another term. Both individuals offered themselves for re-appointment and were found eligible under Section 152 of the Companies Act, 2013.

Director DIN Action
Tulsi Prasad Sharma 09619078 Re-appointed as director liable to retire by rotation
Rowena Sharma 01234567 Re-appointed as director liable to retire by rotation

The Board of Directors' report and the Auditors' report on these financial statements were also considered and adopted by the members.

Meeting details and attendance

The AGM commenced at 3:08 pm and concluded at 3:18 pm. Premjit Singh Kashyap, Chairman and Director, presided over the session after declaring the quorum present. The notice convening the AGM and the Auditor's Report were taken as read with shareholder consent.

Key personnel present included:

  • Shalini Sharma, Managing Director
  • Premjit Singh Kashyap, Chairman and Director
  • Mohd Harris, Independent Director
  • Meenaakashi Elhence, Director
  • Rowena Sharma, Director
  • Amitabh Krishna Bhatia, Independent Director
  • Anil Elhence, Director
  • Tulsi Prasad Sharma, Director
  • Ravi Karan, Independent Director

Sarat Jain served as the scrutinizer to ensure transparent voting via remote e-voting. The Company Secretary noted that e-voting remained open for 15 minutes following the conclusion of the meeting.

Historical Stock Returns for Dhanvantri Jeevan Rekha

1 Day5 Days1 Month6 Months1 Year5 Years
-4.77%0.0%-6.57%+3.38%-16.80%0.0%

How will the re-appointment of Tulsi Prasad Sharma and Rowena Sharma influence the company's strategic direction for the upcoming fiscal year?

What specific operational or financial growth targets were outlined in the Board of Directors' report adopted during the 33rd AGM?

Are there any planned capital expenditure or expansion initiatives mentioned in the audited financial statements that could impact future liquidity?

Dhanvantri Jeevan Rekha
View Company Insights
View All News
like20
dislike

Dhanvantri Jeevan Rekha revenue rises 14% in FY26; profit dips

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Operating income rose 14.17% YoY to ₹258.58 crore in FY26
  • Net profit fell 23% to ₹39.07 lakh due to rising operational costs
  • Earnings per share dropped to ₹0.94 from ₹1.60 in the previous year
  • Company remains debt-free with no long-term borrowings
  • AGM scheduled for September 29, 2026, for director reappointments
powered bylight_fuzz_icon
50076634

*this image is generated using AI for illustrative purposes only.

Dhanvantri Jeevan Rekha Limited reported a 14.17% rise in operating income for FY26, but net profit fell 23% year-on-year as higher costs offset top-line growth. The healthcare provider will convene its 33rd Annual General Meeting on Tuesday, September 29, 2026.

The company’s standalone financial results for the fiscal year ended March 31, 2026, show continued expansion in hospital services despite margin compression. Profit after tax stood at ₹39.07 lakh compared to ₹50.61 lakh in FY25.

Financial Performance

Operating income increased to ₹258.58 crore from ₹226.50 crore in the previous year. However, other income declined from ₹41.40 lakh to ₹32.93 lakh. Total expenses rose sharply to ₹257.88 crore from ₹225.08 crore, driven by higher professional fees to doctors and medical consumables costs.

Metric FY26 (₹ in lakhs) FY25 (₹ in lakhs) Change
Operating Income 2,585.84 2,265.03 +14.17%
Other Income 32.93 41.40 -20.46%
Profit Before Tax 40.00 55.59 -28.04%
Profit After Tax 39.07 50.61 -22.78%

Earnings per share (basic) dropped to ₹0.94 from ₹1.60 in FY25. The company remained debt-free during the period, with no long-term borrowings secured.

What the Numbers Show

While revenue growth indicates strong patient inflow or service utilization, the divergence between top-line growth and bottom-line contraction highlights cost pressures. Professional fees to doctors rose 10.8% to ₹80.87 crore, and employee benefit expenses increased 10.4% to ₹52.98 crore. These operational costs outpaced revenue growth, compressing the net profit ratio from 2.90% in FY25 to 1.49% in FY26.

Director Reappointments

The Board recommends the reappointment of Mr. Tulsi Prasad Sharma and Mrs. Rowena Sharma, both retiring by rotation. They are eligible under the Companies Act, 2013.

Director DIN Date of Appointment Age Nationality
Mr. Tulsi Prasad Sharma 09619078 May 5, 2022 57 years Indian
Mrs. Rowena Sharma 02477356 September 30, 2021 71 years Indian

Mr. Sharma has experience in administrative support, while Mrs. Sharma holds a B.Com degree. Neither director nor their relatives have financial interests in the resolutions beyond their shareholdings.

Meeting Logistics

The AGM will be held exclusively through video conferencing or other audio-visual means (VC/OAVM). Physical attendance is not permitted. Members can join 15 minutes before and after the scheduled start time of 3:00 pm.

Remote e-voting commences on Saturday, September 26, 2026, at 9:00 am and ends on Monday, September 28, 2026, at 5:00 pm. The cut-off date for voting eligibility is Tuesday, September 22, 2026. Central Depository Services (India) Limited (CDSL) facilitates the e-voting process.

Corporate Governance

CA Sarat Jain serves as the Scrutinizer for the remote e-voting process. The Register of Members and Share Transfer Books will remain closed from Wednesday, September 23, 2026, to Tuesday, September 29, 2026. M/s Anuj Goyal & Co. are the statutory auditors for the year.

Historical Stock Returns for Dhanvantri Jeevan Rekha

1 Day5 Days1 Month6 Months1 Year5 Years
-4.77%0.0%-6.57%+3.38%-16.80%0.0%

What specific cost-control measures or pricing strategies will Dhanvantri Jeevan Rekha implement to reverse the margin compression caused by rising professional fees and medical consumables?

How does the company plan to sustain its 14% revenue growth trajectory in FY27 given the current pressure on net profit margins?

Will the reappointment of long-serving directors bring any new strategic initiatives to address the divergence between top-line growth and bottom-line performance?

Dhanvantri Jeevan Rekha
View Company Insights
View All News
like20
dislike

More News on Dhanvantri Jeevan Rekha

1 Year Returns:-16.80%